Related Experiment Video
Updated: May 16, 2026
06:08
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
Vascular actions of aldosterone
Marie Briet1, Ernesto L Schiffrin
1Université Paris Descartes, Faculté de Medicine, Assistance Publique des Hôpitaux de Paris, Hôpital Européen Georges Pompidou, INSERM CIC 9201, Paris, France.
Journal of Vascular Research
|November 23, 2012
Summary
Aldosterone directly harms blood vessels, contributing to cardiovascular risk and metabolic syndrome complications. Blocking the mineralocorticoid receptor (MR) is a key therapy for various cardiovascular diseases.
Area of Science:
- Cardiovascular Science
- Endocrinology
- Vascular Biology
Background:
- Aldosterone directly impacts the vascular system, causing oxidative stress, inflammation, and endothelial dysfunction.
- Aldosterone signaling occurs via genomic and nongenomic pathways, involving mineralocorticoid receptors (MR) and potentially others like GPR30.
- Elevated aldosterone levels correlate with cardiovascular risk and are implicated in metabolic syndrome complications.
Purpose of the Study:
- To review the direct vascular effects of aldosterone.
- To discuss the pathways and receptors involved in aldosterone's action.
- To highlight the role of aldosterone in metabolic syndrome and the therapeutic implications of MR blockade.
Main Methods:
- Literature review and synthesis of existing research on aldosterone's vascular effects.
- Analysis of the interplay between aldosterone, angiotensin II, and endothelin-1 pathways.
- Examination of clinical evidence supporting mineralocorticoid receptor blockade.
Main Results:
- Aldosterone induces vascular damage through oxidative stress, inflammation, remodeling, fibrosis, and endothelial dysfunction.
- Aldosterone acts through MR-dependent and independent pathways, with other receptors like GPR30 identified.
- Therapeutic blockade of MR is an established treatment for hypertension, heart failure, chronic kidney disease, and diabetes mellitus.
Conclusions:
- Aldosterone plays a significant role in vascular pathology and cardiovascular disease progression.
- Understanding aldosterone's mechanisms is crucial for managing cardiovascular risk, especially in metabolic syndrome.
- Mineralocorticoid receptor antagonists are vital in treating a range of cardiovascular and metabolic conditions.
More Related Videos
Related Concept Videos
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
01:33Hormonal Regulation
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
01:17Antihypertensive Drugs: Action of β1 Blockers
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
01:17Hormonal Regulation of Blood Pressure
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
01:25Antihypertensive Drugs: Direct Renin Inhibitors
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...